ClinicalTrials.gg
CompletedNCT07912918Updated Nov 3, 2026

the Effect of Exercise on Sexual Function and Quality of Life in Postpartum Women

An interventional study of Resistance Exercise in Sexual Health, Quality of Life and Postpartum Women, sponsored by Isfahan University of Medical Sciences. Completed at 1 site in Iran. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Isfahan University of Medical Sciences · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jan 2025, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Non-randomized
Sex
Female
01

Study summary

The goal of this clinical trial is to learn if resistance exercise works to promote sexual health or quality of life in postpartum women. The main questions it aims to answer are:

Can a set of physical exercises lead to an improvement in women's perception of their quality of life or their sexual function during the postpartum period? Researchers are comparing the effect of these exercises with routine postpartum care.

Participants will:

Mothers who are two months postpartum (following a vaginal delivery), provided they meet specific criteria-such as having a healthy infant and exclusive breastfeeding.

02

Conditions studied

  • Sexual Health
  • Quality of Life
  • Postpartum Women

Keywords

  • Quality of life
  • sexual health
  • Postpartum Period
03

In context

Lead sponsor

Isfahan University of Medical Sciences is the lead sponsor of 150 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a willingness to participate in the study
  • Iranian nationality and residence in Isfahan
  • Living with spouse and resuming sexual activity after childbirth
  • Primiparous (normal vaginal delivery) and a lapse of two months since delivery
  • Delivery at term (more than 37 weeks) and a healthy infant
  • Reading and writing literacy
  • Exclusive breastfeeding
  • Willingness to engage in physical exercise, the motor ability required to perform the exercises, and the absence of motor disabilities (It is examined in person by the researcher)
  • Normal : BMI (19.8-26 kg/m²)
  • The mother is on maternity leave (returning to work-particularly in arduous or physically demanding jobs-could influence the study variables

Exclusion criteria

Exclusion Criteria:

  • History of underlying medical conditions (confirmed by a physician or documented in the electronic health record)
  • History of severe mental illness requiring hospitalization during pregnancy or the postpartum period
  • Disabilities and structural and mobility issues
  • Below-normal sexual function (scoring less than 28 on FSFI)
  • Active sore or lesion in the genital area (which was examined by the researcher if its presence was suspected)
  • Presence of uterine prolapse, cystocele, and grade 4 rectocele-conditions the patient complained of and which were confirmed by the researcher through visual inspection during the examination
  • Drug and alcohol use (recreational or chronic)
  • Use of medications affecting sexual function
  • Maintaining an active lifestyle or engaging in sports-whether professionally or regularly-during the preconception, pregnancy, or postpartum periods, such that it becomes part of their daily routine
  • Pregnancy-related changes that have not yet returned to the pre-pregnancy state, such as preeclampsia, gestational diabetes, and gestational hypertension
  • If the mother suffered from severe joint pain that hindered her ability to perform daily activities, she was excluded from the study, in addition to being referred to the appropriate specialists for treatment and management of her condition
  • Difficult delivery (using vacuum and forceps) or third- or fourth-degree perineal tear
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • No intervention
    Control group (routine postnatal care)

    Control

  • Experimental
    Resistance Exercise

    Other: Resistance Exercise

Interventions

  • OtherResistance Exercise

    At the intervention centers, a suitable location was designated for instruction on how to perform the exercises during the first four weeks. To ensure privacy, participants received individual, face-to-face training from the researcher and practiced the exercise program once under the researcher's supervision during the first session. At the end of the fourth week of the intervention, participants received individual, face-to-face instruction on how to perform the exercises for the subsequent four weeks.The program consisted of three exercise sessions per week, with each session lasting 50 minutes. Each session included a general warm-up emphasizing the muscle groups involved in that session (5-10 minutes), six resistance exercises (35 minutes), and a cool-down period (5 minutes). The exercises remained the same over each two-week period; however, the number of sets and repetitions increased in the second week.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in the Mean score of Female Sexual function index at 8 weeks

    The Female Sexual Function Index (FSFI) was first developed and validated by Rosen in 2000 . It consists of 19 items that assess sexual function across six domains over the past four weeks: desire (items 1 and 2), sexual arousal (items 3-6), lubrication (items 7-10), orgasm (items 11-13), pain (items 14-16), and sexual satisfaction (items 17-19). A score of 0 indicates that the individual has not engaged in sexual activity during the past four weeks. The total score for the questionnaire is obtained by summing the scores from all six domains; a higher score indicates better sexual function .

    Time frame: Before the intervention begins and after it concludes-which is at the end of the 8th week following the start of the intervention-this questionnaire is completed by participants in both groups as a self-report measure.

  2. Change from Baseline in the Mean score of Short Form Health Survey (SF-36) at 8 weeks.

    The overall score ranges from 0 to 100, where 0 represents the worst state and 100 represents the best.This self-report questionnaire, primarily used to assess quality of life and health, was developed by Ware and Sherbourne. It consists of 36 items and evaluates eight domains: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, mental health, vitality, bodily pain, and general health. Furthermore, the SF-36 provides two summary measures of functioning: the Physical Component Summary (PCS) score, which assesses the physical dimension of health, and the Mental Component Summary (MCS) score, which evaluates the psychosocial dimension of health.

    Time frame: Before the intervention begins and after it concludes-which is at the end of the 8th week following the start of the intervention-this questionnaire is completed by participants in both groups as a self-report measure.

07

Study locations

1 site
  • Shahid Navab Safavi Comprehensive Health Service Center in Isfahan
    Isfahan, Isfahan, Iran
08

References and documents

Individual participant data

Plan to share: Yes — only Study Protocol, Informed Consent Form (ICF), Clinical Study Report (CSR) will be shared.

Supporting information: Study protocol, Informed consent form, Clinical study report

Time frame: 6 months after the publication of the first article.

Access criteria: The information mentioned will be sent only to the researchers' valid email addresses, following the review of their request by the corresponding author of the article.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912918
Responsible party
Kobra Salehi (Assistant professor, Isfahan University of Medical Sciences) — Principal investigator
First posted
Nov 3, 2026
Start date
Jan 19, 2025
Primary completion
Nov 21, 2025
Completion
Nov 21, 2025
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion